Cargando…

Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial

BACKGROUND: Online platforms are used to manage aspects of our lives including health outside clinical settings. Little is known about the effectiveness of using online platforms to manage hypertension. We assessed effects of tweeting/retweeting cardiovascular health content by individuals with poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancheno, Christina, Asch, David A., Klinger, Elissa V., Goldshear, Jesse L., Mitra, Nandita, Buttenheim, Alison M., Barg, Frances K., Ungar, Lyle H., Yang, Lin, Merchant, Raina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649152/
https://www.ncbi.nlm.nih.gov/pubmed/34558301
http://dx.doi.org/10.1161/JAHA.120.020596
_version_ 1784610936591482880
author Mancheno, Christina
Asch, David A.
Klinger, Elissa V.
Goldshear, Jesse L.
Mitra, Nandita
Buttenheim, Alison M.
Barg, Frances K.
Ungar, Lyle H.
Yang, Lin
Merchant, Raina M.
author_facet Mancheno, Christina
Asch, David A.
Klinger, Elissa V.
Goldshear, Jesse L.
Mitra, Nandita
Buttenheim, Alison M.
Barg, Frances K.
Ungar, Lyle H.
Yang, Lin
Merchant, Raina M.
author_sort Mancheno, Christina
collection PubMed
description BACKGROUND: Online platforms are used to manage aspects of our lives including health outside clinical settings. Little is known about the effectiveness of using online platforms to manage hypertension. We assessed effects of tweeting/retweeting cardiovascular health content by individuals with poorly controlled hypertension on systolic blood pressure (SBP) and patient activation. METHODS AND RESULTS: We conducted this 2‐arm randomized controlled trial. Eligibility included diagnosis of hypertension; SBP >140 mm Hg; and an existing Twitter account or willingness to create one to follow study Twitter account. Intervention arm was asked to tweet/retweet health content 2×/week using a specific hashtag for study duration (6 months). The main measures include primary outcome change in SBP; secondary outcome point change in Patient Activation Measure (PAM). We remotely recruited and enrolled 611 participants, mean age 52 (SD, 11.7). Mean baseline SBP for the intervention group was 155.8 and for control was 155.6. At 6 months, mean SBP for intervention group was 137.6 and for control was 135.7. Mean change in SBP from baseline to 6 months for the intervention group was −18.5 and for control was −19.8 (P=0.48). Mean PAM at baseline for the intervention group was 70.3 for control was 72.7. At 6 months, mean PAM scores were 71.1 (intervention) and 75.6 (control). Mean change in PAM score for the intervention group was 0.0 and for control was 3.3 (P=0.12). CONCLUSIONS: Recruiting and engaging patients and collecting outcome measures remotely are feasible using Twitter. Encouraging patients with poorly controlled hypertension to tweet or retweet health content on Twitter did not improve SBP or PAM score at 6 months. REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02622256.
format Online
Article
Text
id pubmed-8649152
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86491522022-03-21 Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial Mancheno, Christina Asch, David A. Klinger, Elissa V. Goldshear, Jesse L. Mitra, Nandita Buttenheim, Alison M. Barg, Frances K. Ungar, Lyle H. Yang, Lin Merchant, Raina M. J Am Heart Assoc Original Research BACKGROUND: Online platforms are used to manage aspects of our lives including health outside clinical settings. Little is known about the effectiveness of using online platforms to manage hypertension. We assessed effects of tweeting/retweeting cardiovascular health content by individuals with poorly controlled hypertension on systolic blood pressure (SBP) and patient activation. METHODS AND RESULTS: We conducted this 2‐arm randomized controlled trial. Eligibility included diagnosis of hypertension; SBP >140 mm Hg; and an existing Twitter account or willingness to create one to follow study Twitter account. Intervention arm was asked to tweet/retweet health content 2×/week using a specific hashtag for study duration (6 months). The main measures include primary outcome change in SBP; secondary outcome point change in Patient Activation Measure (PAM). We remotely recruited and enrolled 611 participants, mean age 52 (SD, 11.7). Mean baseline SBP for the intervention group was 155.8 and for control was 155.6. At 6 months, mean SBP for intervention group was 137.6 and for control was 135.7. Mean change in SBP from baseline to 6 months for the intervention group was −18.5 and for control was −19.8 (P=0.48). Mean PAM at baseline for the intervention group was 70.3 for control was 72.7. At 6 months, mean PAM scores were 71.1 (intervention) and 75.6 (control). Mean change in PAM score for the intervention group was 0.0 and for control was 3.3 (P=0.12). CONCLUSIONS: Recruiting and engaging patients and collecting outcome measures remotely are feasible using Twitter. Encouraging patients with poorly controlled hypertension to tweet or retweet health content on Twitter did not improve SBP or PAM score at 6 months. REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02622256. John Wiley and Sons Inc. 2021-09-24 /pmc/articles/PMC8649152/ /pubmed/34558301 http://dx.doi.org/10.1161/JAHA.120.020596 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Mancheno, Christina
Asch, David A.
Klinger, Elissa V.
Goldshear, Jesse L.
Mitra, Nandita
Buttenheim, Alison M.
Barg, Frances K.
Ungar, Lyle H.
Yang, Lin
Merchant, Raina M.
Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title_full Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title_fullStr Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title_full_unstemmed Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title_short Effect of Posting on Social Media on Systolic Blood Pressure and Management of Hypertension: A Randomized Controlled Trial
title_sort effect of posting on social media on systolic blood pressure and management of hypertension: a randomized controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649152/
https://www.ncbi.nlm.nih.gov/pubmed/34558301
http://dx.doi.org/10.1161/JAHA.120.020596
work_keys_str_mv AT manchenochristina effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT aschdavida effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT klingerelissav effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT goldshearjessel effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT mitranandita effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT buttenheimalisonm effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT bargfrancesk effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT ungarlyleh effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT yanglin effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial
AT merchantrainam effectofpostingonsocialmediaonsystolicbloodpressureandmanagementofhypertensionarandomizedcontrolledtrial